A novel bidirectional ultra-wideband over-fiber (UWBoF) system compatible with the wavelength-division-multiplexing (WDM) architecture is presented. In the proposed scheme, a 6th order Gaussian derivative is generated for UWB transmission in a downstream (DS) scenario, based on the directly modulated laser, accumulative chromatic dispersion in the transmission fiber and delay-line-interferometer (DLI). While the UWB signal is received from one of the DLI outputs, the other output is utilized to reuse the wavelength by injection locking a colorless Fabry-Perot laser diode (FP-LD). Due to the filtering effect of the FP-LD, a clear optical carrier without intensity modulation is then generated which can be used for upstream (US) baseband (BB) transmission by directly modulating the FP-LD. In order to eliminate the unwanted Rayleigh scattering induced noise in the bidirectional transmission, a dual - fiber transmission architecture is used. The principle of operation is explained. A symmetric transmission of 1.25 Gbps UWB over 60 km single mode fiber (SMF) is performed. Bit-error-rate (BER) measurements and eye diagrams for both down and upstream transmissions are presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.25.006840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Pycnanthus angolensis (Welw) Warb., Myristicaceae, is used extensively in ethnomedicine. Numerous health benefits have being ascribed to the use of different parts of P.
View Article and Find Full Text PDFBackground: Alzheimer's Disease (AD) is the leading form of senile dementia, affecting ∼6 million Americans and having a national economic impact of $321 billion, numbers expected to double by 2050. The major pathological hallmarks of AD include Amyloid Beta (Aβ) plaques and Tau neurofibrillary tangles (NFT). The first goal of this research was to develop novel forms of carbon dots (CD) using various precursors.
View Article and Find Full Text PDFDrug Development.
Alzheimers Dement
December 2024
Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China.
Background: Cerebral small vessel disease (CSVD) is one of the most common nervous system diseases. Hypertension and neuroinflammation are considered important risk factors for the development of CSVD and white matter (WM) lesions.
Method: We used the spontaneously hypertensive rat (SHR) as a model of early-onset CSVD and administered epimedium flavonoids (EF) for three months.
Drug Development.
Alzheimers Dement
December 2024
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Background: Our limited understanding of the mechanisms that trigger the emergence of Alzheimer's disease (AD) has contributed to the lack of interventions that stop, prevent, or fully treat this disease. We believe that developing a nonhuman primate model of AD will be an essential step toward overcoming the limitations of other model systems and is crucial for investigating primate-specific mechanisms underlying the cellular and molecular root causes of the pathogenesis and progression of AD.
Method: The consortium successfully generated viable founders carrying PSEN1 mutations.
Drug Development.
Alzheimers Dement
December 2024
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Background: Cognitive decline associated with Alzheimer's disease (AD) correlates with hyperphosphorylated tau (pTau) propagating between neurons along networks connected by synapses. It has been hypothesized this transcellular transmission occurs partially by extracellular vesicles (EVs). Both genetic and pharmacological inhibition of nSMase2 has been found to inhibit EV biogenesis and pTau propagation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!